Sex Differences in Spontaneous Coronary Artery Dissection: A Report of the iSCAD Registry.
Jan 14, 2026DOI: 10.1161/jaha.125.042773Journal ArticleAHA
Written by: Lori M TamSahar NaderiGerald ChiHeather L GornikBryan J WellsDaniella Kadian-DodovAnna GrodzinskyAngela M TaylorConnie N HessJennifer LeweyStanislav HenkinJames L OrfordKathryn J LindleyGretchen L WellsRina MauricioMichelle L OuelletteJeffrey TrostAgnes KoczoStephanie SaucierDaniela R CrousillatSonia TolaniJason C KovacicC Michael GibsonKatherine K LeonMalissa J WoodEsther S H Kim
The iSCAD registry is a multicenter, prospective registry that includes enrolling sites from around the United States and Australia.9 The registry is funded by the SCAD Alliance, a nonprofit patient organization, and data are housed and analyzed by the coordinating center, the Perfusion Fundational Study Evaluation (PERFUSE) group.10 The PERFUSE group was also the core laboratory used for central adjudication of coronary angiograms. This report includes data collected from the first 23 sites participating in the iSCAD registry, and each site received approval for the study from its local institutional review boards. The data collected for this study will not be made publicly available.Patients were eligible for inclusion if they were aged >18 years, had angiographically confirmed SCAD, were able to consent for the study, and could complete electronic patient questionnaires in English. Patients could be enrolled prospectively at the time of an acute SCAD or could also be enrolled if they had a history of SCAD with coronary angiograms that confirmed the diagnosis. On enrollment, patients received questionnaires on their demographic information and medical, family, and social histories. Gender identity was reported by patients. Female and male sex was based on sex at birth and collected by the investigators in the baseline clinical case report form. Enrolling sites completed case report forms detailing presenting symptoms, laboratory data, electrocardiographic findings, medications, hospital course, and imaging results for FMD and other extravascular abnormalities (dissection, aneurysm, or pseudoaneurysm). An in‐hospital major adverse cardiovascular event (MACE) was defined as a composite of myocardial infarction (MI), cerebrovascular accident, or heart failure requiring diuretic therapy.Study data were collected and managed using Research Electronic Data Capture tools hosted at Beth Israel Deaconess Medical Center. Research Electronic Data Capture is a secure, web‐based software platform designed to support data capture for research studies, providing (1) an intuitive interface for validated data capture, (2) audit trails for tracking data manipulation and export procedures, (3) automated export procedures for seamless data downloads to common statistical packages, and (4) procedures for data integration and interoperability with external sources.11, 12Continuous data were expressed as means±SDs as well as medians and interquartile ranges. Categorical data were expressed as frequency counts and percentages. The analysis included individuals who met the enrollment criteria and completed the baseline clinical case report form, regardless of the completion status of questionnaire and core laboratory adjudication of angiography. Study participants were analyzed by sex, as defined above. This analysis used the Sex and Gender Equity in Research guidelines for the reporting of sex.13 Sex is categorized as female or male and is based on a set of biological attributes including chromosomes, gene expression, hormone function, and reproductive/sexual anatomy. Cross‐tabulation of sex by gender was performed (Table S1). Subanalysis was done by patient‐reported gender and reported in the supplementary appendix (Tables S2–S4). Patient characteristics, presentations, and in‐hospital events were compared by sex using the χ2 test for categorical variables and the Kruskal–Wallis test for continuous variables, respectively. The 95% CIs were computed using the Clopper–Pearson method. Missing data were excluded from the analyses. All analyses were performed using 2‐sided tests at a significance level of 0.05 with the SAS version 9.4 (SAS Institute, Inc., Cary, NC).
RESULTS
Of 1252 patients who enrolled in the iSCAD registry from 2019 to 2023, 80 (6.4%) were men (sex at birth; Table 1). Among the 935 participants who were female sex by birth in our study, 5 identified as a man by gender, with 1 individual who opted not to say (Table S1). Among the 60 participants who were male sex by birth, 2 individuals identified as a woman by gender. A total of 257 subjects did not report gender.
Patient Baseline Characteristics by Sex
IQR indicates interquartile range.
Kruskal–Wallis P value.
χ2 P value.
Recreational substances include opiates and opioids, benzodiazepines, amphetamines, 3,4‐methylenedioxymethamphetamine, hallucinogens, carisoprodol, and ketamine. Autoimmune disorders include rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, type 1 diabetes, Guillain–Barre syndrome, chronic inflammatory demyelinating polyneuropathy, psoriasis, Graves disease, and Hashimoto disease. Inherited connective tissue disorders include α1‐antitrypsin deficiency, vascular Ehlers–Danlos syndrome, Loeys–Dietz syndrome, Marfan syndrome, and autosomal dominant polycystic kidney disease. Systemic inflammatory disorders include Behçet disease, celiac disease, Crohn disease, giant cell arteritis, Kawasaki disease, polyarteritis nodosa, rheumatoid arthritis, sarcoidosis, systemic lupus erythematosus, and ulcerative colitis.
Mean age at time of SCAD event did not differ between sexes (men, =50.2±10.3, women, 49.7±10.4; P=0.792). Cardiovascular risk factors including smoking, diabetes, dyslipidemia, hypertension, and history of myocardial infarction or stroke/transient ischemic attack were similar between men and women. There was no significant difference between men and women in the prevalence of inherited connective tissue disorder (3.8% men versus 1.3% women; P=0.139), extracoronary vascular abnormalities (43.9% men versus 50.6% women; P=0.321), anxiety (18.8% men versus 24.5% women; P=0.246), and depression (16.3% men versus 18.3% women; P=0.652) as noted on the case report form (Table 1). Men had lower rates of underlying autoimmune conditions (8.3% men versus 19.8% women; P=0.029), systemic inflammatory disorder (0% men versus 7.4% women; P=0.025), fibromuscular dysplasia (26.3% men versus 41.0% women; P=0.028), and migraine headaches (21.7% men versus 47.2% women; P<0.001) (Table 1). Men had higher rates of recreational substance use (18.6% men versus 10.4% women; P=0.049) (Table 1).
Sex differences in potential precipitating triggers were noted (Table 1, Figure). Women were more likely to report emotional stress preceding SCAD (2.5% men versus 10.2% women; P=0.025). Men more often reported physical stress preceding SCAD (22.5% men versus 7.7% women; P<0.001), both isometric exertion (12.5% men versus 2.4% women; P<0.001) and aerobic exertion (12.5% men versus 5.6% women; P=0.013).
A, Patient characteristics and triggers; (B) SCAD presentations; (C) angiographic characteristics and in‐hospital outcomes. CVA indicates cerebrovascular accident; HF, heart failure; MACE, major adverse cardiovascular event; MI, myocardial infarction; NSTEMI, non–ST‐segment–elevation myocardial infarction SCAD, spontaneous coronary artery dissection; STEMI, ST‐segment–elevation myocardial infarction; VF, ventricular fibrillation; and VT, ventricular tachycardia.
Clinical presentations and angiographic characteristics are reported in Table 2. Chest discomfort was the most common presenting symptom of SCAD in both women and men (71.3% men versus 68.6% women; P=0.621). There were sex differences in presenting symptoms, with women reporting a higher prevalence of non–chest discomfort of neck/jaw/shoulder/arm/back discomfort (48.8% men versus 60.2% women; P=0.044), shortness of breath (17.5% men versus 30.1% women; P=0.016), and nausea/vomiting (16.3% men versus 27.6% women; P=0.026). Time from symptom onset to hospital presentation (<24 hours: 88.4% men versus 82.5% women; 24–48 hours: 4.3% men versus 7.0% women; >48 hours: 7.2% men versus 10.6% women; P=0.447) and time from hospital presentation to coronary angiography were not significantly different between the sexes (<24 hours: 79.5% men versus 74.7% women; 24–48 hours: 16.4% men versus 20.2% women; >48 hours: 4.1% men versus 5.1% women; P=0.667). There was no significant sex differences in clinical presentation of SCAD: ST‐segment–elevation MI (30.0% men versus 27.6% women; P=0.637), non–ST‐segment–elevation MI (46.3% men versus 55.8% women; P=0.096), cardiogenic shock (0% men versus 0.3% women; P=0.601), cardiac arrest (2.5% men versus 4.4% women; P=0.426), ventricular tachycardia (2.5% men versus 0.9% women; P=0.144) and ventricular fibrillation (0% men versus 1.9% women; P=0.216). There was no significant difference in the territory of SCAD involvement (left main artery: 0% men versus 0.7% women; P=0.52; left anterior descending artery: 49.1% men versus 60.6% women; P=0.098, left circumflex artery: 47.2% men versus 37.6% women; P=0.164; right coronary artery: 26.4% men versus 22.9% women; P=0.553) and no significant difference in the prevalence of multivessel SCAD (20.8% men versus 18.9% women; P=0.741). Men were more likely than women to have type 1 SCAD (26.4% men versus 12.5% women; P=0.004). There was no significant difference in the use of intravascular ultrasound/optical coherence tomography during coronary angiography (5.0% men versus 7.3% women; P=0.433).
Clinical Presentations and Angiographic Characteristics by Sex
IQR indicates interquartile range; and SCAD, spontaneous coronary artery dissection
χ2 P value.
Kruskal–Wallis P value.
In‐hospital outcomes, length of stay, and management are reported in Table 3. There was no significant difference between the men and women for in‐hospital outcomes, including MACE (composite of MI, cerebrovascular accident, or heart failure) (4.1% men versus 8.5% women; P=0.178), in‐hospital recurrent MI (3.8% men versus 3.9% women; P=0.948), heart failure requiring diuretics at the time of the index SCAD admission (0% men versus 3.8% women; P=0.085), new arrhythmias (5.1% men versus 7.7% women; P=0.398), ventricular fibrillation (0% men versus 3.2% women; P=0.106), or ventricular tachycardia (3.8% men versus 2.8% women; P=0.590). There was also no significant difference in management strategy for the current SCAD (noninvasive medical management: 75.9% men versus 74.5% women; percutaneous coronary intervention: 24.1% men versus 22.3% women; coronary artery bypass grafting: 0% men versus 1.9% women; percutaneous coronary intervention and coronary artery bypass grafting: 0% men versus 1.3% women; P=0.448). The median length of stay was 3.0 (interquartile range, 3.0–4.0) days for men versus 4.0 (interquartile range, 3.0–5.0) days for women (P=0.003). After excluding pregnancy‐associated SCAD, the median length of stay for women (4 [interquartile range, 3.0–5.0] days) remained longer than men (3.0 [interquartile range, 3.0–4.0] days; P=0.004). There were no differences in rates of discharge on angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers, or β blockers. Men were more likely to be discharged on a statin (72.5% men versus 55.3% women; P=0.003). At discharge, women were more likely to be prescribed single antiplatelet therapy (32.5% men versus 40.9% women), and men were more often prescribed dual antiplatelet therapy (DAPT) (66.3% men versus 53.7% women; P=0.049).
Management and In‐Hospital Outcomes by Sex
IQR indicates interquartile range; and SCAD, spontaneous coronary artery dissection.
χ2 P value.
Kruskal–Wallis P value.
DISCUSSION
While men make up a minority of patients affected by SCAD, the impact of SCAD on the lives of male SCAD survivors cannot be underestimated.I feel like I have just been told that an assassin has boarded a bus with a loaded gun. I just don’t know which route he took, so I don’t know how long it is going to take for him to get here to kill me. ‐‐ Charlie, 2‐time SCAD and sudden cardiac arrest survivor [source: “The Last Ordinary Hour”]14
I feel like I have just been told that an assassin has boarded a bus with a loaded gun. I just don’t know which route he took, so I don’t know how long it is going to take for him to get here to kill me. ‐‐ Charlie, 2‐time SCAD and sudden cardiac arrest survivor [source: “The Last Ordinary Hour”]14
In conversation and on social media, we have seen targeted efforts to reach out to and support men with SCAD. The situation of the male patient with SCAD is not unlike a female patient back in the early 2000s, when the understanding of SCAD was that it occurred only related to pregnancy. How many men are dismissed or misdiagnosed because of the preconceived notion that SCAD affects only women aged <50 years or pregnant women? Continued research, clearly, is needed to study SCAD for the benefit of all survivors.
This report of the iSCAD registry is the largest series of men with SCAD in the United States and provides important insight into the sex differences in demographics, clinical presentation, and characteristics of SCAD. Previously published cohorts reported that 8.7% to 13% of subjects with SCAD were men.6, 8, 15 This is the first study of sex differences in SCAD in which analyses were done both by sex at birth and sex by gender. It is important to note that sex is a biologic variable and gender is a social construct. Sex and gender each affect cardiovascular risk, and the American Heart Association and the National Institutes of Health have advocated for incorporating both sex and gender in cardiovascular disease research.16 There was no significant difference in age between female and male participants in this study, which differs from other studies that have demonstrated younger age in male patients.7, 8 Similar to other studies, the prevalence of traditional risk factors for atherosclerotic cardiovascular disease between women and men were similar and low overall.8 This accounts for the finding that SCAD is a nonatherosclerotic condition. Up to 90% of cases of FMD in the general population occur in women. The prevalence of FMD in this study was higher than expected in men compared with the general population but lower than women in the study, which is similar to previous reports.8, 17 However, despite the higher prevalence of FMD in women, the presence of any extracoronary vascular abnormalities (FMD, dissection, aneurysm, or pseudoaneurysm) was higher than expected and not significantly different between the 2 groups, suggesting that an underlying predisposing vasculopathy may be present in both sexes. The high rates of extracoronary vascular abnormalities beyond just FMD suggest that underlying vascular fragility or predisposition regardless of the underlying pathophysiology of the arteriopathy is an important contributor to the risk of SCAD. Our analysis found that men had lower rates of underlying autoimmune conditions, systemic inflammatory disorder, and migraine. In the general population, women have a higher prevalence of autoimmune conditions,18 systemic inflammatory disorder,19 and migraine20 so this finding may reflect the higher rates of these conditions seen in women overall. The rates of autoimmune disease in our study are higher than other series, and this is potentially attributable to differences in the definition of autoimmune disease among studies.
We found that women reported higher rates of emotional stress preceding SCAD, while men more often reported physical stress, both aerobic and isometric exertion. This is consistent with findings from other publications.8 Interestingly, the prevalence of an emotional trigger preceding SCAD in this study is lower than that reported on a Canadian cohort, which may be attributable to differences in how the study questions were asked or recall bias.8 Although women were more likely to report emotional stress preceding SCAD, the rates of depression preceding SCAD were not significantly different between women and men in our study. This differs from the general population and other reports that have noted higher rates of depression and anxiety in female patients.6, 8, 21 Interestingly, although there was no significant sex difference in the prevalence of depression and anxiety in our study, emotional stress preceding SCAD was still more commonly identified by female patients, suggesting that emotional stressors beyond a background of depression or anxiety may contribute to increased risk for SCAD. When subanalysis was done by patient‐reported gender rather than sex, 2 additional patients were included in the men category, which resulted in the category of emotional stress preceding SCAD as nonsignificant. This is likely attributable to a power issue due to the small sample size given that fewer patients elected to self‐report gender.
Type 1 SCAD was more common in male patients in our study. Type 1 SCAD is characterized by contrast dye staining that shows separation of the arterial wall resulting in ≥2 lumens.22 Type 2 SCAD demonstrates a diffuse luminal narrowing of the coronary artery, and type 3 SCAD is a focal or tubular stenosis that can be difficult to differentiate from atherosclerosis without intravascular imaging. Type 1 SCAD is generally the most straightforward and easy‐to‐recognize SCAD lesion. Thus, it is possible that given the lower reported prevalence of SCAD in men, unless there is a clear separation of the arterial wall on coronary angiography, acute coronary syndrome events in male patients are more often “presumed” to be due to atherosclerosis rather than SCAD. This may result in the underreporting of types 2 and 3 SCAD in men.
Our study demonstrates higher rates of recreational drug use in men with SCAD in a much larger cohort than prior reports.15 Cases of SCAD associated with cocaine and marijuana use have been reported in the literature.23, 24 It has been hypothesized that the increased sympathetic drive from these recreational drugs increase heart rate, blood pressure, and shear stress on vessel walls and may be associated with coronary artery spasm.23 Of note, both recreational drug use and type 1 SCAD were more often seen in men in our study. It would be interesting to consider whether the increased sympathetic drive and shear stress from recreational drugs may impact the dissection pattern seen.
Chest discomfort was the most common presenting symptom in female and male patients with SCAD. This finding is similar to other studies that examine presenting symptoms of acute coronary syndrome more broadly.25 Our study found that women are more likely to also present with nonchest pain symptoms, such as non–chest discomfort, shortness of breath, and nausea/vomiting, which may represent accompanying symptoms of ischemia. This is not unique to SCAD, as women with acute coronary syndrome in general are less likely to report chest pain as their chief complaint compared with men and are more likely to report other non–chest pain symptoms such as nausea, shoulder pain, and upper back pain.26 The differences in presenting symptoms between the sexes should be taken into consideration in the formulation of diagnosis pathways, as this may contribute to delayed recognition and management of SCAD, and a number of SCAD cases are still missed. Consistent with prior studies, there was no significant difference between the male and female in‐hospital MACE (composite of MI, cerebrovascular accident, or heart failure) or clinical outcomes, including recurrent MI, heart failure, and ventricular arrhythmia.8 However, our study did demonstrate a longer length of stay in women. In the non‐SCAD population, the higher prevalence of non–chest pain symptoms reported by women may cause women to underestimate their symptoms or attribute it to a noncardiac cause27 which may lead to delayed recognition of ACS and more peri‐MI complications, resulting in a longer length of stay. However, in our study, the time from symptom onset to hospital presentation and time from hospital presentation to coronary angiography between the sexes did not significantly differ, which suggests that additional factors other than recognition of ACS symptoms also contribute to longer length of stay. Although more complex territories of coronary involvement such as multivessel SCAD or SCAD of the left main artery can contribute to a longer length of stay, there was no difference in the prevalence of multivessel or left main SCAD in our study. Patients who present with pregnancy‐associated SCAD have been reported to have higher‐risk presentations with higher prevalence of left main and multivessel coronary artery disease and lower ejection fraction,28 which could result in more complicated hospitalizations and a longer length of stay, but our study found that even after excluding pregnancy‐associated SCAD, the length of stay for women was longer than that for men. Ongoing ischemia or recurrent MI are potential drivers of longer hospitalizations; however, our analysis did not find a difference in the rate of current MI during the index hospitalization. There was also no significant difference in the prevalence of peri‐MI complications, such as left ventricular dysfunction, cardiogenic shock, or ventricular arrhythmias. The management strategy in terms of the rates of coronary artery bypass grafting or percutaneous coronary intervention during the most recent SCAD hospitalization did not differ significantly between women and men, so the longer length of stay was not driven by the need for open heart surgery or procedures. Since women report higher prevalence of emotional stress preceding their SCAD event compared with men,8 it is possible that a mental stress component, potentially with associated physical symptoms, contributes to longer hospitalization despite the absence of any significant difference in clinical outcomes or MACEs between the sexes.
The use of β blockers has been associated with a decreased risk of recurrent SCAD29 in earlier studies with small sample sizes, although the most recent update from the Canadian SCAD registry did not demonstrate this association in a prospective fashion30 and further research is needed to clarify this important management question. In this study, the rates of β blockers at discharge were similar for both sexes. There was no significant difference in baseline hyperlipidemia history, low‐density lipoprotein cholesterol levels, or history of coronary and noncoronary atherosclerosis between men and women in our study. Expert consensus has noted that statins are not usually indicated in SCAD unless meeting indications for statin therapy based on primary prevention guidelines or presence of any atherosclerosis.1 However, in our study, men were more likely to be discharged on statin medication. Sex disparity in patients after acute MI have demonstrated that women are less likely to be prescribed statin medications.31, 32 However, in the case of SCAD, where statins are not usually indicated in the absence of atherosclerosis, this could potentially represent “reverse bias” in which men are disproportionately more often prescribed statins due to possible uncertainty that atherosclerosis is not a contributor in male patients with SCAD. Alternatively, the high rate of statins on discharge in men may be due to higher 10‐year atherosclerotic cardiovascular disease scores in the pooled cohort equation in men compared with women33 so more men meet atherosclerotic cardiovascular disease criteria for statins independent of the SCAD event.
Current guideline‐based medical therapy for acute coronary syndrome usually involves DAPT for 1 year followed by lifelong therapy with low‐dose aspirin, but the role and duration of DAPT remains an area of uncertainty in the medical management of SCAD.1 Data from a European registry found that DAPT was associated with increased adverse cardiovascular events.34 In our study, men were more likely to be prescribed DAPT, but there was no significant difference in MACEs between the sexes. Further research in larger cohorts is necessary to determine whether there is a role for DAPT in the medical management of SCAD.
This study includes questionnaires with self‐reporting of SCAD triggers and symptoms, so there could potentially be recall bias, in particular with regard to emotional and physical stress before SCAD. Certain self‐reported baseline characteristics such as recreational drug use may have been underreported. Although this study collected data on both sex and gender, other gender categories such as nonbinary were not included. The sample size according to sex at birth versus gender is small and limits the ability to draw significant conclusions. All statistical comparisons were unadjusted for potential confounding variables. The absence of statistically significant sex differences in our study does not preclude the possibility of true associations that may be masked by confounding factors, such as differential distribution of SCAD types between men and women. Multivariable adjustment in future studies will be essential to clarify these relationships.
As is inherent in registry‐based research, there is the possibility of referral bias such that there may be underrepresentation of patients who presented with “less severe” forms of SCAD and underrepresentation of patients who are too sick to participate in research (including those who died from SCAD). All the study sites evaluated for vascular abnormalities at the time of the index hospitalization or the screening for FMD may be delayed until after discharge due to other contributing factors (ie, desire to limit contrast dye load given recent angiography), so the prevalence of FMD may be underreported. The iSCAD registry is unique in that it was developed in partnership with patients with SCAD and includes targeted outreach on social media with referral for enrollment at clinical sites. Women participate in social media and use the Internet more for health information–related searches more frequently than men35, 36 and this could contribute to lower recruitment of male patients. Given that this was an observational study, findings are clinical associations and do not confer causality.
CONCLUSIONS
This is the first study of sex differences in SCAD in which analyses were done by sex versus gender. In contrast with other SCAD registries that include cohorts from only a single center or limited sites, an important strength of this study is the multicenter nature of this cohort, which included 23 sites throughout the United States. In this large population of patients with SCAD, women reported higher rates of emotional stress preceding SCAD, while men reported physical stress/exertion as a trigger. Although chest pain was the most common presenting symptom of SCAD, symptoms in women were more likely to include non–chest discomfort symptoms. Women had higher rates of FMD, autoimmune conditions, systemic inflammatory disorders, and migraine. Men had a higher prevalence of recreational drug use. The clinical presentation, coronary territory of involvement, management strategy, and in‐hospital outcomes were similar between sexes, which has been described in previous reports,8 but this was the first study to report longer hospital length of stay for SCAD in women. This is also the first study to report that men were more likely to be prescribed statins and DAPT at discharge. There is a higher prevalence of extravascular screening than most previously reported studies of SCAD. This study illustrates some important sex differences in the triggers and presentation of SCAD and, importantly, reflects the findings of contemporary, real‐life medical practice in the treatment of patients with SCAD in the United States. Further research in this area is necessary to better understand the underlying mechanisms that precipitate SCAD and potential differences in terms of impact between the sexes.
Sources of Funding
This study was funded by Spontaneous Coronary Artery Dissection Alliance, a 501(c)(3) nonprofit organization, and did not receive any industry support.
Disclosures
Dr Kadian‐Dodov is a consultant for Boston Scientific and Abbott Laboratories; Dr Taylor is a consultant and on the Medical Advisory Board for Boston Scientific; and Dr Saucier is a member of the speakers bureau for Amgen and Novartis Pharmaceuticals. All other authors have no financial disclosures or relationships with industry to report.
Supporting information
Tables S1–S4
MW
Dr. Malissa Wood
Cardiology · Preventive CardiologyWomen As OnemalissaFort Myers, FL, USA